Abstract:Introduction: As a promising clinic therapy of type 1 diabetes, islet transplantation was limited by graft failure. The primary nonimmune obstructive factor was reactive oxygen species (ROS), which causing by intraperitoneal hypoxia environment. The generation of ROS leads sets of downstream reactions, such as Damage-associated molecular patterns (DAMPs) release, oxidative stress (OS), mitochondrial dysfunction, endoplasmic reticulum stress (ERS), inflammation, even apoptosis. C1q/tumor necrosis factor related protein 9 (CTRP9) is a recently discovered adipokine, which has diverse physiological functions, including mitigate OS, alleviate inflammation and suppress apoptosis in various organs. In this study, an islet cells overexpressing CTRP9 gene were established, and the engineering islets are aiming to prolong the graft survival. Methods: Mouse islets were isolated by Liberase RT and the adeno-associated virus (AAV) mediated murine CTRP9 gene was transferred to the syngeneic suboptimal islets. The expression of CTRP9 at mRNA and protein level in engineering islets were measured by RT-qPCR and western blot (WB). In vitro, the engineering islets were incubated at hypoxia environment (1% O2) for 72 hours. The ERS markers, mitochondrial function, anti-oxidative enzymes, ROS generation, and the islets survival rate were detected. Then 200 engineering islets were transplanted to each diabetic mouse under the left kidney capsule, and the blood-glucose level were detected every other day. Results: The CTRP9 mRNA and protein level of the engineering islet were significantly higher than control islets. After 72h hypoxia treatment, the overexpression of CTRP9 significantly decreased the hypoxia-induced ERS markers (GRP78, CHOP, IRE1α), and the ROS generation (ROS, NOS, NO). While it improved the mitochondrial function of islets, the expression of anti-oxidative enzymes (SOD2, Trx1, Catalase), and survival rate. In vivo, engineering islet transplanted mice achieved euglycemia at earlier time. The TUNEL staining and insulin immunohistochemical (IHC) staining of the transplanted grafts showed that the islets transferred with CTRP9 had less apoptosis and more insulin positive cells than control ones. Conclusion: AAV mediated CTRP9 enhances the isolated murine islet anti-hypoxia ability and extended the islet graft survival time. And this study provided a clinic approach for islet homeo-transplantation. the National Key Research and Development Program (Grant No. 2019YFA0110703).

Biological hypoxia in pre-transplant human pancreatic islets induces transplant failure in diabetic mice

Induction of beta‐cell resistance to hypoxia and technologies for oxygen delivery to transplanted pancreatic islets

The Fate of Allogeneic Pancreatic Islets following Intraportal Transplantation: Challenges and Solutions

Innovations in bio-engineering and cell-based approaches to address immunological challenges in islet transplantation

Comprehensive analysis of gene expression of isolated pancreatic islets during pretransplant culture

1729-P: Role of ß-Cell Senescence in Islet Transplantation

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice

Effect of Thioketal Antioxidants on Islet Cell Transplantation

Improvement of Massive Human Islet Isolation Techniques and the Evaluation of Isolated Human Islets

Impact of oxygen and glucose availability on the viability and connectivity of islet cells: A computational study of reconstructed avascular human islets

A Novel Immunodeficient Hyperglycemic Mouse Carrying the Ins1 Akita Mutation for Xenogeneic Islet Cell Transplantation

Brown Adipose Tissue as a Unique Niche for Islet Organoid Transplantation: Insights From In Vivo Imaging

Inflammatory and hypoxic stress-induced islet exosomes released during isolation are associated with poor transplant outcomes in islet autotransplantation

Relevance of hyperglycemia on the timing of functional loss of allogeneic islet transplants: implication for mouse model

Impact of Prevascularization on Immunological Environment and Early Engraftment in Subcutaneous Islet Transplantation

Co-transplantation of Islets-Laden Microgels and Biodegradable O2-Generating Microspheres for Diabetes Treatment

Enhancing human islet xenotransplant survival and function in diabetic immunocompetent mice through LRH-1/NR5A2 pharmacological activation

Posttransplant oxygen inhalation improves the outcome of subcutaneous islet transplantation: A promising clinical alternative to the conventional intrahepatic site

315.5: Overexpression of CTRP9 Mediated by AAV Prevents Graft Loss after Islet Transplantation

Small molecules exert anti-apoptotic effect and reduce oxidative stress augmenting insulin secretion in stem cells engineered islets against hypoxia

The use of non-heart-beating donors for isolated pancreatic islet transplantation.